Mahamaya Lifesciences
MAHAMAYALIFESCIENCESLTD NSE
Mahamaya Lifesciences
ChemicalsNSE: MAHAMAYALIFESCIENCESLTD BSE: 544611 Pesticides & Agrochemicals
Key Fundamentals
SMEPesticides & AgrochemicalsChemicalsMarket Cap
₹433 Cr
Volatility
Moderate
P/E Ratio
25.9
EBITDA
₹33.10 Cr
Return on Equity
26.19%
Debt to Equity
0.75
Book Value
₹52.09
52W High
₹205.05
52W Low
₹111
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
1- Though the company is reporting repeated profits, it is not paying out dividend
Growth Rate
Revenue Growth
23.08% lower than
3Y
Net Income Growth
31.94% lower than
3Y
Cash Flow Change
102% higher than
3Y
ROE
23.77% higher than
3Y
ROCE
11.19% lower than
3Y
EBITDA Margin (Avg.)
3.29% lower than
3Y
Quarterly Results
| Particulars | Sep 2024 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 146 | 163 | 166 |
| Expenses | 133 | 148 | 149 |
| Operating Profit | 13 | 15 | 17 |
| OPM % | 9% | 9% | 10% |
| Other Income | 1 | 1 | 1 |
| Interest | 4 | 4 | 4 |
| Depreciation | 1 | 1 | 1 |
| PBT | 10 | 11 | 12 |
| Tax % | 27% | 27% | 35% |
| Net Profit | 7 | 8 | 8 |
| EPS in Rs | 4.08 | 4.71 | 3.48 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 90 | 137 | 161 | 264 | 329 |
| Expenses | 84 | 128 | 148 | 241 | 296 |
| Operating Profit | 6 | 9 | 13 | 23 | 34 |
| OPM % | 7% | 6% | 8% | 9% | 10% |
| Other Income | 0 | 0 | 1 | 3 | 1 |
| Interest | 2 | 3 | 6 | 7 | 8 |
| Depreciation | 1 | 1 | 1 | 2 | 2 |
| PBT | 4 | 5 | 7 | 17 | 24 |
| Tax % | 27% | 26% | 27% | 25% | 31% |
| Net Profit | 3 | 4 | 5 | 13 | 17 |
| EPS in Rs | 21.78 | 30.03 | 41.8 | 7.28 | 7.06 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 18 | 23 |
| Reserves | 14 | 18 | 23 | 32 | 99 |
| Borrowings | 19 | 24 | 55 | 58 | 91 |
| Other Liabilities | 21 | 34 | 33 | 81 | 98 |
| Total Liabilities | 56 | 78 | 112 | 188 | 310 |
| Fixed Assets | 20 | 21 | 21 | 27 | 38 |
| CWIP | 2 | 2 | 3 | 4 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 34 | 54 | 88 | 157 | 267 |
| Total Assets | 56 | 78 | 112 | 188 | 310 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 2 | 1 | -23 | 1 | -30 |
| Investing | -3 | -3 | -2 | -8 | -16 |
| Financing | 1 | 2 | 24 | 9 | 81 |
| Net Cash Flow | 0 | 1 | 0 | 1 | 35 |
| Free Cash Flow | -1 | -2 | -25 | -8 | -46 |
| CFO/OP | 56 | 24 | -162 | 12 | -75 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 37 | 25 | 64 | 67 | 78 |
| Inventory Days | 93 | 109 | 137 | 167 | — |
| Days Payable | 83 | 87 | 61 | 92 | — |
| Cash Conversion Cycle | 47 | 48 | 140 | 142 | 78 |
| Working Capital Days | 8 | 9 | 14 | 29 | 49 |
| ROCE % | — | 20% | 21% | 26% | 20% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Mahamaya Lifesciences insights
29 extracted metrics + investor summaries across FY22–FY26.
Documents
1
Compliances-Reg.24(A)-Annual Secretarial Compliance
5 May - Company says Annual Secretarial Compliance Report for FY2026 is not applicable under Regulation 24A. 5 May - Company says Annual Secretarial Compliance Report for FY2026 is not applicable under Regulation 24A.
4
Announcement Under Regulation 30(LODR)-Receiving A Certification-"Great Place To Work
28 Apr - Awarded Great Place to Work certification for Under 100 Employees, valid April 2026 to April 2027. 28 Apr - Awarded Great Place to Work certification for Under 100 Employees, valid April 2026 to April 2027.
5
Announcement Under Regulation 30(LODR)-Receiving A Certification-"Great Place To Work
28 Apr - Awarded Great Place to Work certification for Under 100 Employees, valid April 2026 to April 2027. 28 Apr - Awarded Great Place to Work certification for Under 100 Employees, valid April 2026 to April 2027.
Frequently Asked Questions about Mahamaya Lifesciences
What does Mahamaya Lifesciences Ltd do?
ncorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management.[1]
Where is Mahamaya Lifesciences Ltd (544611) listed?
Mahamaya Lifesciences Ltd trades as MAHAMAYALIFESCIENCESLTD on the NSE and under code 544611 on the BSE.
Which sector does Mahamaya Lifesciences Ltd belong to?
Mahamaya Lifesciences Ltd is classified under the Chemicals sector, in the Pesticides & Agrochemicals industry.
What is the market capitalisation of Mahamaya Lifesciences Ltd?
Mahamaya Lifesciences Ltd has a market capitalisation of ₹432.98 Cr, which places it in the Small Cap band.
What is the PE ratio of Mahamaya Lifesciences Ltd?
Mahamaya Lifesciences Ltd trades at a PE ratio of 25.90, against a book value of ₹52.09 per share.
What is the 52-week high and low of Mahamaya Lifesciences Ltd?
Over the last 52 weeks Mahamaya Lifesciences Ltd has traded between ₹111 and ₹205.05.
What is the Return on Equity (ROE) of Mahamaya Lifesciences Ltd?
Mahamaya Lifesciences Ltd reported a return on equity of 26.19%. Its debt-to-equity ratio is 0.75.
Company Information
ncorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544611.md for Mahamaya Lifesciences Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.